Evidence map›Paper›PMID 34504246›Full record

ArticleScientific reports2021

Diagnostic classification of coronavirus disease 2019 (COVID-19) and other pneumonias using radiomics features in CT chest images.

Ning Yang, Faming Liu, Chunlong Li, Wenqing Xiao, Shuangcong Xie, Shuyi Yuan, Wei Zuo, Xiaofen Ma, Guihua Jiang

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Pulmonary contusion volume and radiomics as predictors of early-onset pneumonia in trauma patients, a retrospective single-centre study.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2025
    Observational
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. A review on advances inInsights into imaging · 2022
    Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ning Yang *Department of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou, 510317, People's Republic of China.
Faming Liu *Radiology Department, Xiao Chang First People's Hospital, Hubei, People's Republic of China.
Chunlong LiMajoring in Imaging and Nuclear Medicine, Graduate School, Guangdong Medical University, Guangzhou, People's Republic of China.
Wenqing XiaoDepartment of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou, 510317, People's Republic of China.
Shuangcong XieDepartment of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou, 510317, People's Republic of China.
Shuyi YuanEquipment Department, Guangdong Second Provincial General Hospital, Guangzhou, People's Republic of China.
Wei ZuoDepartment of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou, 510317, People's Republic of China.
Xiaofen MaDepartment of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou, 510317, People's Republic of China. xiaofenma12@163.com.
Guihua JiangDepartment of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou, 510317, People's Republic of China. jianggh@gd2h.org.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We propose a classification method using the radiomics features of CT chest images to identify patients with coronavirus disease 2019 (COVID-19) and other pneumonias. The chest CT images of two groups of participants (90 COVID-19 patients who were confirmed as positive by nucleic acid test of RT-PCR and 90 other pneumonias patients) were collected, and the two groups of data were manually drawn to outline the region of interest (ROI) of pneumonias. The radiomics method was used to extract textural features and histogram features of the ROI and obtain a radiomics features vector from each sample. Then, we divided the data into two independent radiomic cohorts for training (70 COVID-19 patients and 70 other pneumonias patients), and validation (20 COVID-19 patients and 20 other pneumonias patients) by using support vector machine (SVM). This model used 20 rounds of tenfold cross-validation for training. Finally, single-shot testing of the final model was performed on the independent validation cohort. In the COVID-19 patients, correlation analysis (multiple comparison correction-Bonferroni correction, P < 0.05/7) was also conducted to determine whether the textural and histogram features were correlated with the laboratory test index of blood, i.e., blood oxygen, white blood cell, lymphocytes, neutrophils, C-reactive protein, hypersensitive C-reactive protein, and erythrocyte sedimentation rate. The final model showed good discrimination on the independent validation cohort, with an accuracy of 89.83%, sensitivity of 94.22%, specificity of 85.44%, and AUC of 0.940. This proved that the radiomics features were highly distinguishable, and this SVM model can effectively identify and diagnose patients with COVID-19 and other pneumonias. The correlation analysis results showed that some textural features were positively correlated with WBC, and NE, and also negatively related to SPO2H and NE. Our results showed that radiomic features can classify COVID-19 patients and other pneumonias patients. The SVM model can achieve an excellent diagnosis of COVID-19.

Indexed as

Support Vector MachineAdultBiomedical EngineeringBlood SedimentationCOVID-19C-Reactive ProteinFemaleHumansLeukocyte CountLungMaleMiddle AgedPneumoniaSARS-CoV-2Tomography, X-Ray ComputedC-Reactive Protein

Identifiers

PMID34504246
PMCPMC8429652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.